Determination of drug susceptibility of Mycobacterium tuberculosis through mycolic acid analysis with HPLC technique - comparison to the conventional methods

R. Walkiewicz, H. Grubek-Jaworska, R. Chazan (Warsaw, Poland)

Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities
Session: Management of tuberculosis pulmonary, extrapulmonary peculiarities
Session type: Oral Presentation
Number: 4538
Disease area: Respiratory infections

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Walkiewicz, H. Grubek-Jaworska, R. Chazan (Warsaw, Poland). Determination of drug susceptibility of Mycobacterium tuberculosis through mycolic acid analysis with HPLC technique - comparison to the conventional methods. Eur Respir J 2005; 26: Suppl. 49, 4538

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Detection of isoniazid or rifampin resistant Mycobacterium tuberculosis in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005


Comparison of Mycobacterium tuberculosis drug susceptibility tests by nucleic acid amplification and classic technique
Source: Eur Respir J 2001; 18: Suppl. 33, 315s
Year: 2001

In vitro and vivo study of isoxyl, a mycolic acid inhibitor for intermittent chemotherapy of multi drug resistant (MDR) strains of mycobacterium tuberculosis (M.tb)
Source: Eur Respir J 2006; 28: Suppl. 50, 587s
Year: 2006

Comparative analysis of detection of Mycobacterium tuberculosis and rifampin resistance determination through microbiological and molecular genetics methods for pulmonary tuberculosis patients with presence or absence of sputum
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012


Evaluation of a molecular assay for detection of rifampin and isoniazid resistant mycobacterium tuberculosis in strains and clinical samples
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008


Comparative analysis of M. tuberculosis drug susceptibility tests results in new multidrug-resistant tuberculosis cases and their confirmed contacts.
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020


Application of the novel technique next gene sequencing for the determination of mycobacterium tuberculosis resistance in clinical samples
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013

Rapid resistance detection of Mycobacterium tuberculosis to second-line drugs using the manual mycobacterium growth indicator tube (MGIT) system.
Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2008

Microbiology of Mycobacterium tuberculosis and a new diagnostic test for TB
Source: Eur Respir Mon 2012; 58: 1-13
Year: 2012


Simultaneous detection of XDR genetic determinants and Mycobacterium tuberculosis genotyping by TB-TEST.
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017


Method of treatment of destructive tuberculosis of single lung with extensively drug resistant mycobacteria tuberculosis
Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions
Year: 2011

Detection of fluoroquinolones resistance mutations in mycobacterium tuberculosis by hydrolysis probes and RFLP
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013


In vitro and in vivo activity of thiourea (ISO), a mycolic acid inhibitor, against multi drug resistant (MDR) strains of Mycobacterium tuberculosis (M. tb)
Source: Eur Respir J 2005; 26: Suppl. 49, 700s
Year: 2005

Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection
Source: Eur Respir J 2006; 28: 24-30
Year: 2006



Systematic evaluation of clarithromycin (CLA) resistance associated mutations in Mycobacterium abscessus complex based on whole-genome sequencing analysis and drug susceptibility testing.
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020

Application of the method of biological microchips for control drug-resistant mycobacterium tuberculosis
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009


Mycobacterium tuberculosis resistance
Source: Eur Respir J 2002; 20: Suppl. 38, 360s
Year: 2002

The WHO strategy for TB control and elimination
Source: Eur Respir Mon 2012; 58: 242-253
Year: 2012


The compare of the TB-Biochip oligonucleotide microarray system and bacteriological method for detection of rifampin and isoniazid resistance in mycobacterium tuberculosis
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008


Colorimetric assays for rapid drug susceptibility testing of Mycobacterium tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 167s
Year: 2003